Goldstandard Ophthalmopathologie – noch zeitgemäß?

Zusammenfassung

Die Ophthalmopathologie hat eine lange Tradition in Deutschland. Von der kontinuierlichen Weiterentwicklung technischer und molekularbiologischer Methoden profitiert auch dieser spezielle Bereich der allgemeinen Pathologie. Als Basis grundlagenwissenschaftlicher Forschung, aber auch im Bezug auf die Vermittlung pathophysiologischer Zusammenhänge und in der Evaluation innovativer Operationsmethoden ist die Ophthalmopathologie auch heutzutage nicht wegzudenken. Anhand verschiedener Fallbeispiele werden die 4 Säulen der Ophthalmopathologie – die Diagnostik, die klinisch-pathologische Korrelation, die Evaluation neuer Therapiemethoden und die Forschung – illustriert. Die Ophthalmopathologie ist nicht nur ein Fach der Vergangenheit, sondern vor allem ein Fach der Zukunft. Sie entwickelt sich mit dem medizinischen und ophthalmologischen Fortschritt weiter und dient auch dazu, diesen kritisch zu evaluieren. Die klinisch-pathologische Korrelation ist ein unschätzbares Gut für die nachhaltige Qualität der Augenheilkunde, die wir uns nicht durch das „Sparen an falscher Stelle“ (d. h. der Schließung ophthalmopathologischer Labore) leichtfertig nehmen lassen sollten. Die Ophthalmopathologie war, ist und wird weiterhin der Goldstandard bei vielen ophthalmologischen Fragestellungen bleiben.

Abstract

Ophthalmic pathology has a long tradition in Germany. And, like in general pathology, there is continuous progress due to new technologies and the improvement of molecular biology techniques. Ophthalmic pathology cannot be disregarded, particularly in the context of basic research but also as a medium for understanding pathophysiologic interrelationships and evaluating innovative surgical techniques. By means of various examples, the “four columns” of ophthalmic pathology shall be illustrated: diagnostics, clinicopathologic correlation, evaluation of new surgical and medical techniques and finally research. Ophthalmic pathology is not a discipline of the past but is rather one of the future. It develops and improves together with medical and ophthalmological progress and serves, at the same time, as a critical evaluation tool. Clinicopathologic correlations are of paramount importance for a lasting quality in ophthalmology, and we should not risk depriving ourselves of this instrument by carelessly saving at the wrong end and closing our laboratories. Ophthalmic pathology was, is and will further be the gold standard in many aspects of ophthalmology.

Schlüsselwörter

Kornea - okuläre Tumoren - Pathologie

Key words

cornea - ocular tumours - pathology

Publication History

Received: 07 February 2020

Accepted: 09 March 2020

Article published online:
20 May 2020

• Literatur

• 1 Rohrbach JM. Albrecht von Graefe (1828–1870) und die Ophthalmopathologie. Klin Monatsbl Augenheilkd 2015; 232: 1101-1104 doi:10.1055/s-0035-1545738
• 2 Rohrbach JM, Auw-Hädrich C, Messmer EM. et al. Zur Situation der Ophthalmopathologie in Deutschland: eine aktuelle Bestandsaufnahme. Klin Monatsbl Augenheilkd 2009; 226: 740-746 doi:10.1055/s-0028-1109695
• 3 Rokohl AC, Kopecky A, Guo Y. et al. Chirurgische Resektion mit ophthalmoplastischer Rekonstruktion: Goldstandard beim periokulären Basalzellkarzinom. Ophthalmologe 2020; 117: 95-105 doi:10.1007/s00347-019-00973-x
• 4 Herwig-Carl MC, Loeffler KU. Regression of periocular basal cell carcinoma: a report of four cases with clinicopathologic correlation. Ocul Oncol Pathol 2020; 6: 107-114 doi:10.1159/000501370
• 5 Cicinelli MV, Kaliki S. Ocular sebaceous gland carcinoma: an update of the literature. Int Ophthalmol 2019; 39: 1187-1197 doi:10.1007/s10792-018-0925-z
• 6 Jakobiec FA, Mendoza PR. Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin. Am J Ophthalmol 2014; 157: 186-208.e2 doi:10.1016/j.ajo.2013.08.015
• 7 Jakobiec FA, Werdich X. Androgen receptor identification in the diagnosis of eyelid sebaceous carcinomas. Am J Ophthalmol 2014; 157: 687-696.e1–e2 doi:10.1016/j.ajo.2013.12.009
• 8 Schmitz EJ, Herwig-Carl MC, Holz FG. et al. Sebaceous gland carcinoma of the ocular adnexa – variability in clinical and histological appearance with analysis of immunohistochemical staining patterns. Graefes Arch Clin Exp Ophthalmol 2017; 255: 2277-2285 doi:10.1007/s00417-017-3738-2
• 9 Mittal R, Araujo I, Czanner G. et al. Perforin expression in eyelid sebaceous carcinomas: a useful and specific immunomarker for the differential diagnosis of eyelid carcinomas. Acta Ophthalmol 2016; 94: e325-e330 doi:10.1111/aos.12972
• 10 Roth M, Daas L, Renner-Wilde A. et al. Das Deutsche Pilz-Keratitis-Register: Erste Ergebnisse einer multizentrischen Erhebung. Ophthalmologe 2019; 116: 957-966 doi:10.1007/s00347-019-0871-9
• 11 van Essen TH, van Pelt SI, Versluis M. et al. Prognostic parameters in uveal melanoma and their association with BAP1 expression. Br J Ophthalmol 2014; 98: 1738-1743 doi:10.1136/bjophthalmol-2014-305047
• 12 Koopmans AE, Verdijk RM, Brouwer RWW. et al. Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma. Mod Pathol 2014; 27: 1321-1330 doi:10.1038/modpathol.2014.43
• 13 van de Nes JAP, Nelles J, Kreis S. et al. Comparing the prognostic value of BAP1 mutation pattern, chromosome 3 status, and BAP1 immunohistochemistry in uveal melanoma. Am J Surg Pathol 2016; 40: 796-805 doi:10.1097/PAS.0000000000000645
• 14 Kalirai H, Dodson A, Faqir S. et al. Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing. Br J Cancer 2014; 111: 1373-1380 doi:10.1038/bjc.2014.417
• 15 Szalai E, Wells JR, Ward L. et al. Uveal melanoma nuclear BRCA1-associated protein-1 immunoreactivity is an indicator of metastasis. Ophthalmology 2018; 125: 203-209 doi:10.1016/j.ophtha.2017.07.018
• 16 Herwig-Carl MC, Sharma A, Moulin A. et al. BAP1 immunostaining in uveal melanoma: potentials and pitfalls. Ocul Oncol Pathol 2018; 4: 297 doi:10.1159/000486370
• 17 Kenawy N, Lake SL, Coupland SE. et al. Conjunctival melanoma and melanocytic intra-epithelial neoplasia. Eye (Lond) 2013; 27: 142-152 doi:10.1038/eye.2012.254
• 18 Damato B, Coupland SE. Conjunctival melanoma and melanosis: a reappraisal of terminology, classification and staging. Clin Exp Ophthalmol 2008; 36: 786-795 doi:10.1111/j.1442-9071.2008.01888.x
• 19 Folberg R, McLean IW. Primary acquired melanosis and melanoma of the conjunctiva: terminology, classification, and biologic behavior. Hum Pathol 1986; 17: 652-654 doi:10.1016/s0046-8177(86)80175-7
• 20 Herwig-Carl MC, Grossniklaus HE, Müller PL. et al. Pyogenic granuloma associated with conjunctival epithelial neoplasia: report of nine cases. Br J Ophthalmol 2019; 103: 1469-1474 doi:10.1136/bjophthalmol-2018-312960
• 21 Cheng J, Qi X, Zhao J. et al. Comparison of penetrating keratoplasty and deep lamellar keratoplasty for macular corneal dystrophy and risk factors of recurrence. Ophthalmology 2013; 120: 34-39 doi:10.1016/j.ophtha.2012.07.037
• 22 Herwig MC, Holz FG, Loeffler KU. Early histological alteration of the retina following photocoagulation treatment in diabetic retinopathy as measured by spectral-domain optical coherence tomography. Graefes Arch Clin Exp Ophthalmol 2012; 250: 473 doi:10.1007/s00417-011-1687-8
• 23 Koinzer S, Saeger M, Hesse C. et al. Correlation with OCT and histology of photocoagulation lesions in patients and rabbits. Acta Ophthalmol 2013; 91: e603-e611 doi:10.1111/aos.12188
• 24 Zanzottera EC, Messinger JD, Ach T. et al. The project MACULA retinal pigment epithelium grading system for histology and optical coherence tomography in age-related macular degeneration. Invest Ophthalmol Vis Sci 2015; 56: 3253-3268 doi:10.1167/iovs.15-16431
• 25 Sarks SH. Ageing and degeneration in the macular region: a clinico-pathological study. Br J Ophthalmol 1976; 60: 324-341 doi:10.1136/bjo.60.5.324
• 26 Löffler KU, Lee WR. Basal linear deposit in the human macula. Graefes Arch Clin Exp Ophthalmol 1986; 224: 493-501 doi:10.1007/bf02154735
• 27 Mencucci R, Marini M, Paladini I. et al. Effects of riboflavin/UVA corneal cross-linking on keratocytes and collagen fibres in human cornea. Clin Experiment Ophthalmol 2010; 38: 49-56 doi:10.1111/j.1442-9071.2010.02207.x
• 28 Luft N, Schumann RG, Dirisamer M. et al. Wound healing, inflammation, and corneal ultrastructure after SMILE and femtosecond laser-assisted LASIK: a human ex vivo study. J Refract Surg 2018; 34: 393-399 doi:10.3928/1081597X-20180425-02
• 29 Pecorella I, Appolloni R, Tiezzi A. et al. Histological findings in a failed corneal riboflavin-UVA collagen cross-linking performed for progressive keratoconus. Cornea 2013; 32: 191-195 doi:10.1097/ICO.0b013e3182553aac
• 30 Zhang C, Xu J, Chen R. Histology of corneal wound healing after deep lamellar endothelial keratoplasty. Clin Ophthalmol 2008; 2: 217-221
• 31 Schmidt I, Schlötzer-Schrehardt U, Langenbucher A. et al. Ultrastructural findings in graft failure after Descemet membrane endothelial keratoplasty (DMEK) and new triple procedure. Medicine (Baltimore) 2019; 98: e15493 doi:10.1097/MD.0000000000015493
• 32 Schießl G, Suffo S, Milioti G. et al. Muraine-Nähte beschleunigen die Abheilung des Hydrops corneae bei akutem Keratotorus. Ophthalmologe 2019; 116: 665-668 doi:10.1007/s00347-018-0791-0
• 33 Pang A, Mohamed-Noriega K, Chan AS. et al. Confocal microscopy findings in deep anterior lamellar keratoplasty performed after Descemetʼs stripping automated endothelial keratoplasty. Clin Ophthalmol 2014; 8: 243-249 doi:10.2147/OPTH.S54824
• 34 Messmer EM, Meyer P, Herwig MC. et al. Morphological and immunohistochemical changes after corneal cross-linking. Cornea 2013; 32: 111-117 doi:10.1097/ICO.0b013e31824d701b
• 35 Müller PL, Loeffler KU, Messmer E. et al. Histological corneal alterations in keratoconus after crosslinking-expansion of findings. Cornea 2019; DOI: 10.1097/ICO.0000000000002144.
• 36 Müller PL, Löffler KU, Kohlhaas M. et al. Morphologische Hornhautveränderungen nach Crosslinking bei Keratokonus. Klin Monatsbl Augenheilkd 2018; 235: 809-819 doi:10.1055/s-0043-102577
• 37 Eagle RC, Shields CL, Bianciotto C. et al. Histopathologic observations after intra-arterial chemotherapy for retinoblastoma. Arch Ophthalmol 2011; 129: 1416-1421 doi:10.1001/archophthalmol.2011.223
• 38 Kalirai H, Shahidipour H, Coupland SE. et al. Use of the chick embryo model in uveal melanoma. Ocul Oncol Pathol 2015; 1: 133-140 doi:10.1159/000370151
• 39 Kilian MM, Loeffler KU, Pfarrer C. et al. Intravitreally injected HCmel12 melanoma cells serve as a mouse model of tumor biology of intraocular melanoma. Curr Eye Res 2016; 41: 121-128 doi:10.3109/02713683.2015.1004721
• 40 Meyer JH, Larsen PP, Strack C. et al. Optical coherence tomography angiography (OCT-A) in an animal model of laser-induced choroidal neovascularization. Exp Eye Res 2019; 184: 162-171 doi:10.1016/j.exer.2019.04.002
• 41 Süsskind D, Hurst J, Rohrbach JM. et al. Novel mouse model for primary uveal melanoma: a pilot study. Clin Exp Ophthalmol 2017; 45: 192-200 doi:10.1111/ceo.12814
• 42 Yang H, Fang G, Huang X. et al. In-vivo xenograft murine human uveal melanoma model develops hepatic micrometastases. Melanoma Res 2008; 18: 95-103 doi:10.1097/CMR.0b013e3282f628df
• 43 Folberg R, Arbieva Z, Moses J. et al. Tumor cell plasticity in uveal melanoma: microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns. Am J Pathol 2006; 169: 1376-1389 doi:10.2353/ajpath.2006.060223
• 44 Meir T, Zeschnigk M, Masshöfer L. et al. The spatial distribution of monosomy 3 and network vasculogenic mimicry patterns in uveal melanoma. Invest Ophthalmol Vis Sci 2007; 48: 1918-1922 doi:10.1167/iovs.06-1308
• 45 Stålhammar G, See TRO, Phillips SS. et al. Density of PAS positive patterns in uveal melanoma: correlation with vasculogenic mimicry, gene expression class, BAP-1 expression, macrophage infiltration, and risk for metastasis. Mol Vis 2019; 25: 502-516
• 46 Herwig MC, Bergstrom C, Wells JR. et al. M2/M1 ratio of tumor associated macrophages and PPAR-gamma expression in uveal melanomas with class 1 and class 2 molecular profiles. Exp Eye Res 2013; 107: 52-58 doi:10.1016/j.exer.2012.11.012
• 47 Bronkhorst IHG, Ly LV, Jordanova ES. et al. Detection of M2-macrophages in uveal melanoma and relation with survival. Invest Ophthalmol Vis Sci 2011; 52: 643-650 doi:10.1167/iovs.10-5979
• 48 Bronkhorst IHG, Vu THK, Jordanova ES. et al. Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma. Invest Ophthalmol Vis Sci 2012; 53: 5370-5378 doi:10.1167/iovs.11-9280
• 49 Herwig-Carl MC, Loeffler KU, Müller AM. Bedeutung der Untersuchung fetaler Augen: Ergänzung der Fetobduktion. Pathologe 2017; 38: 231-240 doi:10.1007/s00292-017-0289-6
• 50 Herwig MC, Münstermann K, Klarmann-Schulz U. et al. Expression of the lymphatic marker podoplanin (D2–40) in human fetal eyes. Exp Eye Res 2014; 127: 243-251 doi:10.1016/j.exer.2014.07.026
• 51 Herwig MC, Müller AM, Holz FG. et al. Morphologic analysis of artifacts in human fetal eyes confounding histopathologic investigations. Invest Ophthalmol Vis Sci 2011; 52: 2712-2718 doi:10.1167/iovs.10-6301
• 52 Herwig MC, Müller AM, Klarmann-Schulz U. et al. Lens artifacts in human fetal eyes – the challenge of interpreting the histomorphology of human fetal lenses. Graefes Arch Clin Exp Ophthalmol 2014; 252: 155-162 doi:10.1007/s00417-013-2485-2
• 53 Melzer C, Sharma A, Peters S. et al. Basal cell carcinomas developing independently from BAP1-tumor predisposition syndrome in a patient with bilateral uveal melanoma: diagnostic challenges to identify patients with BAP1-TPDS. Genes Chromosomes Cancer 2019; 58: 357-364 doi:10.1002/gcc.22724